Osteoporosis Treatment Under COVID-19

A steering committee of the American Society for Bone Mineral Research recently issued COVID-19 treatment guidelines for patients receiving osteoporosis treatments. In this interview, E. Michael Lewiecki, M.D., director of the New Mexico Clinical Research and Osteoporosis Center and a University of New Mexico program called Bone Health TeleECHO, shares his best practices for treating osteoporosis patients during the pandemic.

Related Content:

Osteoporosis

How COVID-19 Has Altered Assessment and Treatment of Osteoporosis

Zoledronic Acid Associated With Higher Risk for Atrial Fibrillation Than Denosumab

Bisphosphonates Show No Significant Benefit for Hip Fracture Risk after Five Years